Taylor Spector (@tspectorphd) 's Twitter Profile
Taylor Spector

@tspectorphd

Scientist • Lipid Nerd • Mom • Pharmacology PhD • Wife • Medical Affairs Expert • Harry Potter Fanatic • Former D1 Athlete • Lover of Sports • Nutrition Newbie

ID: 928374744872865792

calendar_today08-11-2017 21:32:42

169 Tweet

124 Followers

293 Following

Jennifer Gunter (@drjengunter) 's Twitter Profile Photo

If a drug company said “We made a product. We think it will help but we have done zero studies, not even animal data, but we are going to sell it” would you take it. If the answer is no, why would you use a similarly untested product from a “natural” company?

Michael J. Blaha (@michaeljblaha) 's Twitter Profile Photo

What an incredible day for cardiovascular prevention! Dapagliflozin meets one of its primary endpoints, solidifying the SGLT2i class with 3 CVOTs an CVD-REAL, and this is back page news given the REDUCE-IT study!

C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Nearly 800 dietary supplements contained unapproved drug ingredients, >1 unapproved drug found in 20% of supplements, results in 23,000 ER visits per year CNN cnn.it/2CFIT27

Taylor Spector (@tspectorphd) 's Twitter Profile Photo

Shout out to the passengers and crew of americanair flight 452 to BOS today for their patience! From the mom of the toddler that could win Olympic gold for screaming bloody murder during take off and landing! Thanks for making me feel normal and welcome, screams and all!

C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

HEARTS ♥️ Hard working, hustler Emotionally intelligent, empathetic, entrepreneurial Ambitious Resilient, resourceful Team player Self starter If this is you, and you want a growth experience over the next 2 years, DM me

Taylor Spector (@tspectorphd) 's Twitter Profile Photo

Missing my first AHAMeetings in 10 years and it’s going to be a good one! I’m pretty sad about it, but excited to follow along on twitter!#AHA2018

NEJM (@nejm) 's Twitter Profile Photo

In the REDUCE-IT trial, which involved statin-treated patients with hypertriglyceridemia, the risk of ischemic events, including cardiovascular death, was significantly lower with 4 g of icosapent ethyl daily than with placebo. nej.md/2Owu03E #AHA18

Amit V. Khera (@amitvkhera) 's Twitter Profile Photo

$AMRN REDUCE-IT take: 1. Trial in high TG 2. Used a TG lowering med 3. This is NOT a test of TG lowering I actually agree after seeing results … but messaging complex.

Stacey Rosen, M.D. (@drstaceyrosen) 's Twitter Profile Photo

Insurance companies aren’t doctors. So why do we keep letting them practice medicine? Why indeed? washingtonpost.com/opinions/2019/…

Popular Science (@popsci) 's Twitter Profile Photo

Zulresso is the first FDA-approved medication designed to tackle postpartum depression, and it does so at speed. The Sage Therapeutics product is our #BestOfWhatsNew "Innovation of the Year” winner for 2019. See the full list: pops.ci/best

Zulresso is the first FDA-approved medication designed to tackle postpartum depression, and it does so at speed.

The <a href="/SageBiotech/">Sage Therapeutics</a> product is our #BestOfWhatsNew "Innovation of the Year” winner for 2019.

See the full list: pops.ci/best
Sek Kathiresan MD (@skathire) 's Twitter Profile Photo

History of heart attack; on LDL-lowering statin; triglycerides > 150 Now, important new option to prevent a recurrent heart attack or stroke: U.S. FDA approves Vascepa 2g twice daily 👏🏽Dr. Deepak L. Bhatt Amarin

Merissa Muller (@mmullerpr) 's Twitter Profile Photo

Last week alone, 45 patients sought #psychiatric care at Massachusetts General Hospital and only 6 beds were available. “It’s unimaginable that we’re one of the richest states in the country and continue to face this problem.” -Peter Slavin, president of MGH #bbjhealthcare

Taylor Spector (@tspectorphd) 's Twitter Profile Photo

Working with Marieke Jonkman on this article was fun. But more importantly we learned so much about #impostersyndrome. Notably that I was not alone in my struggles with it throughout my career and there are easy, practical tips to help work through it! #medicalaffairs #coaching

JAMA Dermatology (@jamaderm) 's Twitter Profile Photo

Potent and selective inhibition of TYK2 with zasocitinib at oral doses of 5 mg or more once daily resulted in greater skin clearance than placebo over 12 weeks for treatment of psoriasis, this RCT found. ja.ma/3ALAWHW

Potent and selective inhibition of TYK2 with zasocitinib at oral doses of 5 mg or more once daily resulted in greater skin clearance than placebo over 12 weeks for treatment of psoriasis, this RCT found. ja.ma/3ALAWHW